Li Y - Search Results

1

MALAT1 Promotes Tumorigenesis and Increases Cellular Sensitivity to Herceptin in HER2-positive Breast Cancer.

Yang C, Zhu H, Tan Y, Zhu R, Wu X, Li Y, Wang C. Yang C, et al. Among authors: li y. Curr Cancer Drug Targets. 2021;21(10):860-869. doi: 10.2174/1568009621666210618164300. Curr Cancer Drug Targets. 2021. PMID: 34148540

2

Inhibition of long non-coding RNA ROR reverses resistance to Tamoxifen by inducing autophagy in breast cancer.

Li Y, Jiang B, Zhu H, Qu X, Zhao L, Tan Y, Jiang Y, Liao M, Wu X. Li Y, et al. Tumour Biol. 2017 Jun;39(6):1010428317705790. doi: 10.1177/1010428317705790. Tumour Biol. 2017. PMID: 28635401 Free article.

3

Long non-coding RNA MIAT is estrogen-responsive and promotes estrogen-induced proliferation in ER-positive breast cancer cells.

Li Y, Jiang B, Wu X, Huang Q, Chen W, Zhu H, Qu X, Xie L, Ma X, Huang G. Li Y, et al. Biochem Biophys Res Commun. 2018 Sep 3;503(1):45-50. doi: 10.1016/j.bbrc.2018.05.146. Epub 2018 Jun 15. Biochem Biophys Res Commun. 2018. PMID: 29792859

4

Long noncoding RNA cancer susceptibility candidate 9 promotes doxorubicin‑resistant breast cancer by binding to enhancer of zeste homolog 2.

Jiang B, Li Y, Qu X, Zhu H, Tan Y, Fan Q, Jiang Y, Liao M, Wu X. Jiang B, et al. Among authors: li y. Int J Mol Med. 2018 Nov;42(5):2801-2810. doi: 10.3892/ijmm.2018.3812. Epub 2018 Aug 7. Int J Mol Med. 2018. PMID: 30106089

5

Identification and validation of potential long non-coding RNA biomarkers in predicting survival of patients with head and neck squamous cell carcinoma.

Li J, Li Y, Wu X, Li Y. Li J, et al. Among authors: li y. Oncol Lett. 2019 Jun;17(6):5642-5652. doi: 10.3892/ol.2019.10261. Epub 2019 Apr 17. Oncol Lett. 2019. PMID: 31186787 Free PMC article.

6

Radiomics-based nomogram using CT imaging for noninvasive preoperative prediction of early recurrence in patients with hepatocellular carcinoma.

Zhu HB, Zheng ZY, Zhao H, Zhang J, Zhu H, Li YH, Dong ZY, Xiao LS, Kuang JJ, Zhang XL, Liu L. Zhu HB, et al. Diagn Interv Radiol. 2020 Sep;26(5):411-419. doi: 10.5152/dir.2020.19623. Diagn Interv Radiol. 2020. PMID: 32490826 Free PMC article.

7

circIQCH sponges miR-145 to promote breast cancer progression by upregulating DNMT3A expression.

Li Y, Jiang B, He Z, Zhu H, He R, Fan S, Wu X, Xie L, He X. Li Y, et al. Aging (Albany NY). 2020 Aug 3;12(15):15532-15545. doi: 10.18632/aging.103746. Epub 2020 Aug 3. Aging (Albany NY). 2020. PMID: 32756009 Free PMC article.

8

The Biogenesis and Functions of circRNAs and Their Roles in Breast Cancer.

Tang L, Jiang B, Zhu H, Gao T, Zhou Y, Gong F, He R, Xie L, Li Y. Tang L, et al. Among authors: li y. Front Oncol. 2021 Feb 25;11:605988. doi: 10.3389/fonc.2021.605988. eCollection 2021. Front Oncol. 2021. PMID: 33718157 Free PMC article. Review.

9

Apatinib Inhibits Stem Properties and Malignant Biological Behaviors of Breast Cancer Stem Cells by Blocking Wnt/β-catenin Signal Pathway through Downregulating LncRNA ROR.

Jiang B, Zhu H, Tang L, Gao T, Zhou Y, Gong F, Tan Y, Xie L, Wu X, Li Y. Jiang B, et al. Among authors: li y. Anticancer Agents Med Chem. 2022;22(9):1723-1734. doi: 10.2174/1871520621666210412103849. Anticancer Agents Med Chem. 2022. PMID: 33845750

10

circ-PRKCI targets miR-1294 and miR-186-5p by downregulating FOXK1 expression to suppress glycolysis in hepatocellular carcinoma.

Chen W, Li Y, Zhong J, Wen G. Chen W, et al. Among authors: li y. Mol Med Rep. 2021 Jun;23(6):464. doi: 10.3892/mmr.2021.12103. Epub 2021 Apr 21. Mol Med Rep. 2021. PMID: 33880589 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239,597 results

Search Page

Filters